Shear-reducing insoles to prevent foot ulceration in high-risk diabetic patients

Advances in Skin and Wound Care

Volumn 25, Issue 11, 2012, Pages 519-524

  Lavery, Lawrence A ^a   Lafontaine, Javier ^a   Higgins, Kevin R ^b   Lanctot, Dan R ^c   Constantinides, George ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Diabetica Solutions ^*

^c Diabetica Solutions   (United States)

Author keywords

Diabetic foot ulcers; High risk persons with diabetes; Shear reducing insoles

Indexed keywords

AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT; FEMALE; FOOT ORTHOSIS; HUMAN; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRESSURE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SHEAR STRENGTH; SHOE; TIME;

AGED; DIABETIC FOOT; FEMALE; FOOT ORTHOSES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRESSURE; RISK FACTORS; SHEAR STRENGTH; SHOES; TIME FACTORS;

EID: 84868615652     PISSN: 15277941     EISSN: 15388654     Source Type: Journal    
DOI: 10.1097/01.ASW.0000422625.17407.93     Document Type: Article

References (37)

1. American Diabetes Association. Foot care in patients with diabetes mellitus. Diabetic Care 1997;20(Suppl 1):S31-2.
2. Lavery LA, Ashry HR, van Houtum W, Pugh JA, Harkless LB, Basu S. Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care 1996;19:48-52. (Pubitemid 26006614)
3. Lavery LA, van Houtum WH, Ashry HR, Armstrong DG, Pugh JA. Diabetes-related lower-extremity amputations disproportionately affect Blacks and Mexican Americans. South Med J 1999;92:593-9. (Pubitemid 29270189)
4. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In: Harris MI, Cowie C, Stern MP, eds. Diabetes in America. 2nd ed. NIH Publication 95, 1995:409-28.
5. Reiber GE, Smith DG, Wallace C, et al. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. JAMA 2002;287:2552-8. (Pubitemid 34517201)
6. Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995;18:1376-8.
7. Patton J, Bruce G, Jones R, Stenhouse E. Effectiveness of insoles used for the prevention of ulceration in the neuropathic diabetic foot: a systematic review. J Diabetes Complications 2011;25:52-62.
8. Lavery LA, Vela SA, Fleischli JG, Armstrong DG, Lavery DC. Reducing plantar pressure in the neuropathic foot. A comparison of footwear. Diabetes Care 1997;20:1706-10.
9. Mueller MJ, Strube MJ, Allen BT. Therapeutic footwear can reduce plantar pressures in patients with diabetes and transmetatarsal amputation. Diabetes Care 1997;20:637-41. (Pubitemid 27143429)
10. Reiber GE, Smith DG, Boone DA, et al. Design and pilot testing of the DVA/Seattle Footwear System for diabetic patients with foot insensitivity. J Rehabil Res Dev 1997;34(1):1-8. (Pubitemid 27066446)
11. Laing P, Deogan H, Cogley D, Crerand S, Hammond P, Klenerman L. The development of the low profile Liverpool shear transducer. Clin Phys Physiol Meas 1992;13:115-24.
12. Lord M, Hosein R, Williams RB. Method for in-shoe shear stress measurement. J Biomed Eng 1992;14:181-6.
13. Yavuz M, Tajaddini A, Botek G, Davis BL. Temporal characteristics of plantar shear distribution: relevance to diabetic patients. J Biomech 2008;41:556-9. (Pubitemid 351179716)
14. Zou D, Mueller MJ, Lott DJ. Effect of peak pressure and pressure gradient on subsurface shear stresses in the neuropathic foot. J Biomech 2007;40:883-90. (Pubitemid 46273458)
15. Lavery LA, Lanctot DR, Constantinides G, Zamorano RG, Athanasiou KA, Agrawal CM. Wear and biomechanical characteristics of a novel shear-reducing insole with implications for high-risk persons with diabetes. Diabetes Technol Ther 2005;7:638-46. (Pubitemid 41208629)
16. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994;17:557-60. (Pubitemid 24161977)
17. Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract 2000;49(11 Suppl):S17-29.
18. Lavery LA, Lavery DC, Quebedeax-Farnham TL. Increased foot pressures after great toe amputation in diabetes. Diabetes Care 1995;18:1460-2.
19. Schaper NC, Apelqvist J, Bakker K. The international consensus and practical guidelines on the management and prevention of the diabetic foot. Curr Diab Rep 2003;3(6):475-9. (Pubitemid 38906808)
20. Newrick P. International consensus on the diabetic foot. BMJ 2000;321(7261):642A.
21. Schlesselman J. Case Control Studies: Design, Conduct, Analysis. New York: Oxford University Press; 1982.
22. Mayfield JA, Reiber GE, Nelson RG, Greene T. A foot risk classification system to predict diabetic amputation in Pima Indians. Diabetes Care 1996;19:704-9. (Pubitemid 26249720)
23. Peters EJ, Armstrong DG, Lavery LA. Risk factors for recurrent diabetic foot ulcers: site matters. Diabetes Care 2007;30:2077-9. (Pubitemid 47219423)
24. Peters EJ, Lavery LA; International Working Group on the Diabetic Foot. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2001;24:1442-7. (Pubitemid 33716435)
25. Lavery LA, Peters EJ, Williams JR, Murdoch DP, Hudson A, Lavery DC; International Working Group on the Diabetic Foot. Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2008;31:154-6.
26. Edmonds ME, Blundell MP, Morris ME, Thomas EM, Cotton LT, Watkins PJ. Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med 1986;60:763-71. (Pubitemid 16008592)
27. Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE. Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am 2003;85-A(8):1436-45. (Pubitemid 36951126)
28. Brand PW. Management of the insensitive limb. Phys Ther 1979;59(1):8-12. (Pubitemid 9087010)
29. Brand PW. The Diabetic Foot. New York: Medical Examination Publishing; 1983.
30. Armstrong DG, Lavery LA. Plantar pressures are higher in diabetic patients following partial foot amputation. Ostomy Wound Manage 1998;44(3):30-32, 34, 36 passim.
31. Armstrong DG, Lavery LA. Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician 1998;57:1325-32, 1337-8. (Pubitemid 28139331)
32. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998;158:157-62. (Pubitemid 28049509)
33. Sugarman JR, Reiber GE, Baumgardner G, Prela CM, Lowery J. Use of the therapeutic footwear benefit among diabetic Medicare beneficiaries in three states, 1995. Diabetes Care 1998;21:777-81. (Pubitemid 28487070)
34. Frykberg RG, Armstrong DG, Giurini J, et al. Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. J Foot Ankle Surg 2000;39(5 Suppl):S1-60. (Pubitemid 32224305)
35. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in diabetes. Diabetes Care 2004;27(Suppl 1):S63-4.
36. Grufferman S. Complexity and the Hawthorne effect in community trials. Epidemiology 1999;10:209-10. (Pubitemid 29187750)
37. Lied TR, Kazandjian VA. A Hawthorne strategy: implications for performance measurement and improvement. Clin Perform Qual Health Care 1998;6:201-4.